$FXC
Invesco CurrencyShares Canadian Dollar Trust

2023 Q1 Form 10-Q Financial Statement

#000095017023019005 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $555.2K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $97.10K $137.6K
YoY Change -29.44% -18.54%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $458.1K -$137.6K
YoY Change -432.92% -18.54%
Net Earnings / Revenue 82.51%
Basic Earnings Per Share $0.34 -$0.08
Diluted Earnings Per Share $0.34 -$0.08
COMMON SHARES
Basic Shares Outstanding 1.300M 1.804M
Diluted Shares Outstanding 1.359M 1.804M

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $101.1M $133.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $101.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $39.28K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $101.3M
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $458.1K -$137.6K
YoY Change -432.92% -18.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $407.5K -$146.1K
YoY Change -378.94% -4.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $400.4K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.941M -7.926M
YoY Change -137.11% -129.27%
NET CHANGE
Cash From Operating Activities 407.5K -146.1K
Cash From Investing Activities
Cash From Financing Activities 2.941M -7.926M
Net Change In Cash 3.726M -6.407M
YoY Change -158.15% -121.88%
FREE CASH FLOW
Cash From Operating Activities $407.5K -$146.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001353612
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Invesco CURRENCYSHARES CANADIAN DOLLAR TRUST
CY2023Q1 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-32910
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-6551776
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2023Q1 dei City Area Code
CityAreaCode
800
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2023Q1 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2023Q1 dei Trading Symbol
TradingSymbol
FXC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1400000
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
101101474
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
97375615
CY2023Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
207757
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
156162
CY2023Q1 us-gaap Assets
Assets
101309231
CY2022Q4 us-gaap Assets
Assets
97531777
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities Foreign
NoninterestBearingDepositLiabilitiesForeign
4074
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Foreign
NoninterestBearingDepositLiabilitiesForeign
4080
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
35208
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34248
CY2023Q1 us-gaap Liabilities
Liabilities
39282
CY2022Q4 us-gaap Liabilities
Liabilities
38328
CY2023Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1400000
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1400000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1350000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1350000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
101269949
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
97493449
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101309231
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97531777
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
555232
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023Q1 us-gaap Revenues
Revenues
555232
CY2022Q1 us-gaap Revenues
Revenues
0
CY2023Q1 us-gaap Sponsor Fees
SponsorFees
97096
CY2022Q1 us-gaap Sponsor Fees
SponsorFees
137611
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
97096
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
137611
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
458136
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-137611
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1359444
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1359444
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1804444
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1804444
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
400427
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
458136
CY2023Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-57709
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-137611
CY2022Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
137611
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
458136
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-137611
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
51595
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
960
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-8480
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
407501
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-146091
CY2023Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
400427
CY2022Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0
CY2023Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
39596837
CY2022Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
15373766
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
36255464
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
23299351
CY2023Q1 us-gaap Net Change Noninterest Bearing Deposits Foreign
NetChangeNoninterestBearingDepositsForeign
-6
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2940940
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7925585
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
377418
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1664849
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3725859
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6406827
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97375615
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139650371
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101101474
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133243544
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-06-08
CY2023Q1 fxc Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
CY2023Q1 fxc Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2023Q1 fxc Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B. Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.29
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
400427
CY2023Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-04-11
CY2023Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-04-04
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12035
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
168490
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 fxc Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0233
CY2023Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
53752909
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
48866318
CY2023Q1 us-gaap Cash
Cash
136825680
CY2023Q1 us-gaap Cash
Cash
101101474
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
73340680
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
117356152
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
444805
CY2022Q4 us-gaap Cash
Cash
131939089
CY2022Q4 us-gaap Cash
Cash
97375615
CY2023Q1 fxc Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D

Files In Submission

Name View Source Status
0000950170-23-019005-index-headers.html Edgar Link pending
0000950170-23-019005-index.html Edgar Link pending
0000950170-23-019005.txt Edgar Link pending
0000950170-23-019005-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fxc-20230331.htm Edgar Link pending
fxc-20230331.xsd Edgar Link pending
fxc-ex31_1.htm Edgar Link pending
fxc-ex31_2.htm Edgar Link pending
fxc-ex32_1.htm Edgar Link pending
fxc-ex32_2.htm Edgar Link pending
img29844892_0.jpg Edgar Link pending
img29844892_1.jpg Edgar Link pending
img29844892_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fxc-20230331_def.xml Edgar Link unprocessable
fxc-20230331_cal.xml Edgar Link unprocessable
fxc-20230331_lab.xml Edgar Link unprocessable
fxc-20230331_pre.xml Edgar Link unprocessable
fxc-20230331_htm.xml Edgar Link completed